FAS and ovarian cancer: Gonadotropin-releasing hormone analog (GnRHa) was able to inhibit ovarian cancer cell growth by increasing inositol phosphate levels and initiating protein kinase pathways such as ERK1/2, and also to stimulate ovarian cancer cell apoptosis by increasing expression of apoptosis-associated genes and stimulating the Fas system [55].